Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances

J Pediatr Urol. 2010 Jun;6(3):251-6. doi: 10.1016/j.jpurol.2009.10.011. Epub 2009 Nov 5.

Abstract

Objective: To review the current literature regarding the outcome of endoscopic treatment of vesicoureteric reflux (VUR) using different tissue-augmenting substances, with special emphasis on long-term efficacy.

Material and methods: The current literature, including our own experience, on long-term results after endoscopic treatment was reviewed by MEDLINE/PubMed search.

Results: The short-term results are similar in the majority of series to those of open surgery, but there is a high recurrence rate with use of dextranomer/hyaluronic acid (Deflux) as a tissue-augmenting material.

Conclusions: There is a significant shortage of evidence-based literature on long-term follow-up after endoscopic correction of VUR utilizing dextranomer/hyaluronic acid. The high recurrence rate that has been reported after Deflux injection highlights a need for close observation beyond routine protocols and appropriate parental counseling upon endoscopic correction, and also the need to search further for alternative tissue-augmenting substances. The algorithm for treating VUR is yet to be finally determined.

Publication types

  • Review

MeSH terms

  • Child
  • Endoscopy / methods*
  • Follow-Up Studies
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Injections
  • Polytetrafluoroethylene / administration & dosage*
  • Prosthesis Implantation / methods*
  • Time Factors
  • Treatment Outcome
  • Urodynamics / physiology*
  • Vesico-Ureteral Reflux / physiopathology*
  • Vesico-Ureteral Reflux / surgery*
  • Viscosupplements / administration & dosage*

Substances

  • Viscosupplements
  • Polytetrafluoroethylene
  • Hyaluronic Acid